ADAP is currently covered by 3 analysts with an average potential upside of $3.16 (67.71%) backed by displayed 22 price targets and 29 ratings.
Analysts average stock forecasts to be materialized ratio is 56.67% with an average time for these price targets to be met of 273 days.
Highest price target for ADAP is 6, Lowest price target is 1, average price target is 3.5. For detailed individual stock analysts price targets on ADAP go to the chart section.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 09-Nov-2022. First documented stock forecast 30-Sep-2016.
3/31/00 2 for 1
Currently, out of the existing stock ratings of ADAP - 6 which are a Hold (46.15%), 7 which are a Buy (53.85%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
9
$7.96 (765.38%)
9
6 months 30 days ago
2/3 (66.67%)
$1.29 (98.13%)
340
Hold
3
$1.96 (188.46%)
1 years 30 days ago
6/10 (60%)
$1.52 (33.46%)
85
Sell
4
$2.96 (284.62%)
12
2 years 11 days ago
2/3 (66.67%)
$3.48 (46.66%)
279
Buy
6
$4.96 (476.92%)
16
4 years 1 months 1 days ago
1/3 (33.33%)
$6.36 (92.59%)
388
What is ADAP(Adaptimmune Therapeutics plc) average time for price targets to be met?
Which analyst has the current highest performing score on ADAP(Adaptimmune Therapeutics plc) with a proven track record?
Which analyst has the current lower performing score on ADAP(Adaptimmune Therapeutics plc) with a proven track record?
